Centene Co. (NYSE:CNC) Shares Sold by Clarius Group LLC

Clarius Group LLC reduced its holdings in shares of Centene Co. (NYSE:CNC) by 7.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,003 shares of the company’s stock after selling 324 shares during the quarter. Clarius Group LLC’s holdings in Centene were worth $297,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Coppell Advisory Solutions Corp. acquired a new position in Centene during the fourth quarter worth about $25,000. Turtle Creek Wealth Advisors LLC acquired a new position in Centene during the fourth quarter worth about $25,000. Operose Advisors LLC acquired a new position in Centene during the third quarter worth about $25,000. ST Germain D J Co. Inc. acquired a new position in Centene during the second quarter worth about $26,000. Finally, OFI Invest Asset Management purchased a new stake in Centene during the 3rd quarter worth about $26,000. Institutional investors and hedge funds own 93.63% of the company’s stock.

Analyst Ratings Changes

CNC has been the topic of several analyst reports. Truist Financial raised their price target on shares of Centene from $83.00 to $86.00 and gave the stock a “buy” rating in a research note on Thursday, December 21st. Cantor Fitzgerald reiterated an “overweight” rating and issued a $90.00 price target on shares of Centene in a report on Thursday, April 4th. Barclays assumed coverage on Centene in a report on Wednesday, March 6th. They set an “overweight” rating and a $101.00 price objective on the stock. Wells Fargo & Company dropped their target price on Centene from $94.00 to $89.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Finally, UBS Group lifted their price target on Centene from $72.00 to $79.00 and gave the company a “neutral” rating in a report on Thursday, December 21st. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $85.08.

Centene Stock Performance

NYSE:CNC opened at $70.73 on Monday. Centene Co. has a twelve month low of $60.83 and a twelve month high of $81.42. The firm has a market capitalization of $37.83 billion, a price-to-earnings ratio of 14.41, a PEG ratio of 0.88 and a beta of 0.38. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.68. The firm’s fifty day simple moving average is $76.80 and its 200 day simple moving average is $74.50.

Centene (NYSE:CNC) last released its quarterly earnings results on Tuesday, February 6th. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.43 by $0.02. The firm had revenue of $39.46 billion for the quarter, compared to analyst estimates of $36.16 billion. Centene had a return on equity of 14.26% and a net margin of 1.75%. Centene’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.86 EPS. As a group, equities research analysts expect that Centene Co. will post 6.75 earnings per share for the current fiscal year.

Insider Activity at Centene

In other Centene news, Director Lori Jean Robinson sold 10,000 shares of the company’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $77.41, for a total value of $774,100.00. Following the completion of the transaction, the director now directly owns 11,455 shares of the company’s stock, valued at approximately $886,731.55. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other news, President Kenneth J. Fasola sold 12,000 shares of the business’s stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $75.07, for a total value of $900,840.00. Following the completion of the sale, the president now owns 235,365 shares of the company’s stock, valued at approximately $17,668,850.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Lori Jean Robinson sold 10,000 shares of Centene stock in a transaction dated Tuesday, February 13th. The stock was sold at an average price of $77.41, for a total value of $774,100.00. Following the completion of the transaction, the director now owns 11,455 shares of the company’s stock, valued at $886,731.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.